Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nine Square Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Nine Square Therapeutics

Nine Square Therapeutics

Nine Square Therapeutics develops computational drugs for degenerative and non-degenerative movement disorders.

HQ
New York City, NY, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Nine Square Therapeutics, founded with a mission to revolutionize treatments for movement disorders, focuses on developing small-molecule therapeutics for conditions such as Parkinson’s disease, amyotrophic lateral sclerosis (ALS), essential tremor, and dyskinesias. By integrating computational chemistry and biology, the company aims to accelerate the development of better drugs targeting neurodegenerative diseases.

Notable people affiliated with Nine Square Therapeutics include experts in computational chemistry and neurobiology. The company has garnered attention for its innovative approach and has made significant strides in drug discovery, impacting the field of neurodegenerative disease treatment. Their work promises to alter the trajectory of these debilitating conditions, offering hope for improved patient outcomes.

Nine Square Therapeutics - Similar Companies

NeuroX1 logo

NeuroX1

neurox1.com

Libra Therapeutics logo

Libra Therapeutics

Chaperone Therapeutics logo

Chaperone Therapeutics

Denali Therapeutics logo

Denali Therapeutics

KeifeRx logo

KeifeRx

keiferx.com

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Ajax Therapeutics logo

Ajax Therapeutics

Nobias Therapeutics logo

Nobias Therapeutics

nobiastx.com

TorMagnus Pharmaceuticals logo

TorMagnus Pharmaceuticals

Engrail Therapeutics logo

Engrail Therapeutics

engrail.com

Ensem Therapeutics logo

Ensem Therapeutics

ensemtx.com

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

Santi Therapeutics logo

Santi Therapeutics

Chamishi Therapeutics logo

Chamishi Therapeutics

Inflammasome Therapeutics logo

Inflammasome Therapeutics

inflam.com

Nine Square Therapeutics - Quick Facts

Who are Nine Square Therapeutics' competitors?

Companies similar to Nine Square Therapeutics include NeuroX1, Libra Therapeutics, Chaperone Therapeutics and Denali Therapeutics.

When was Nine Square Therapeutics founded?

Nine Square Therapeutics was founded in 2020.

Where is Nine Square Therapeutics' headquarters located?

Nine Square Therapeutics' headquarters is located in New York City, NY, US.

When was Nine Square Therapeutics' last funding round?

Nine Square Therapeutics' most recent funding round was for $4.5M (USD) in September 2023.

How much has Nine Square Therapeutics raised to-date?

As of Sep 12, 2023, Nine Square Therapeutics has raised a total of $54.5M (USD).

How many employees does Nine Square Therapeutics have?

Nine Square Therapeutics has 17 employees as of Feb 5, 2024.

Nine Square Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • AI Operations
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified